A detailed history of Asset Dedication, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Asset Dedication, LLC holds 1,231 shares of ADPT stock, worth $5,441. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,231
Previous 1,231 -0.0%
Holding current value
$5,441
Previous $4,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

SELL
$3.46 - $5.33 $231 - $357
-67 Reduced 5.16%
1,231 $6,000
Q2 2023

Aug 21, 2023

BUY
$6.19 - $8.78 $414 - $588
67 Added 5.44%
1,298 $8,000
Q2 2021

Jul 21, 2021

BUY
$32.22 - $44.59 $32,252 - $44,634
1,001 Added 435.22%
1,231 $51,000
Q1 2021

May 03, 2021

SELL
$37.26 - $67.74 $4,471 - $8,128
-120 Reduced 34.29%
230 $10,000
Q3 2020

Oct 20, 2020

BUY
$35.79 - $48.81 $6,979 - $9,517
195 Added 125.81%
350 $17,000
Q2 2020

Aug 24, 2020

BUY
$24.95 - $48.38 $3,867 - $7,498
155 New
155 $7,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $631M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Asset Dedication, LLC Portfolio

Follow Asset Dedication, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Dedication, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asset Dedication, LLC with notifications on news.